Cargando…
Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging
Although drug distribution in tumor tissues has a significant impact on efficacy, conventional pharmacokinetic analysis has some limitations with regard to its ability to provide a comprehensive assessment of drug tissue distribution. Erlotinib is a tyrosine kinase inhibitor that acts on the epiderm...
Autores principales: | Tsubata, Yukari, Hayashi, Mitsuhiro, Tanino, Ryosuke, Aikawa, Hiroaki, Ohuchi, Mayu, Tamura, Kenji, Fujiwara, Yasuhiro, Isobe, Takeshi, Hamada, Akinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626687/ https://www.ncbi.nlm.nih.gov/pubmed/28974758 http://dx.doi.org/10.1038/s41598-017-13025-8 |
Ejemplares similares
-
Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging
por: Nishimura, Meiko, et al.
Publicado: (2018) -
Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging
por: Ryu, Shoraku, et al.
Publicado: (2020) -
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells
por: Nishidate, Masanobu, et al.
Publicado: (2017) -
Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging
por: Aikawa, Hiroaki, et al.
Publicado: (2016) -
Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance
por: Tsubata, Yukari, et al.
Publicado: (2021)